Q1 2025 Donaldson Company Inc Earnings Call Transcript
Key Points
- Donaldson Co Inc (DCI) reported record first-quarter earnings, marking a strong start to fiscal 2025 with increased sales across all three segments.
- The company achieved strong sales growth in mobile solutions despite weak end market conditions, supported by higher volumes and mix benefits from the aftermarket business.
- Industrial solutions saw excellent performance in the Aerospace and Defense business, with a notable increase in both new and replacement part sales.
- Life sciences sales increased double digits, driven by share gains and improved market conditions in disk drive and strength in the food and beverage business.
- Donaldson Co Inc (DCI) maintained strong gross margins and improved operating margin through leverage on higher sales, contributing to an 11% increase in adjusted EPS year over year.
- Life sciences segment reported a pretax loss of approximately $5 million, with challenges from acquisitions and difficult market conditions.
- Off-road sales in mobile solutions were down 6% due to sustained weak end market conditions, particularly in the global agriculture market.
- On-road sales decreased by 15%, driven by lower equipment production predominantly in the US and China.
- Industrial solutions experienced a decline in pretax profit margin due to increased costs and an unfavorable sales mix.
- Supply chain constraints continue to affect some areas of the business, particularly in the Aerospace and Defense segment, impacting project deliveries.
Thank you for standing by, and welcome to the Donaldson Company first-quarter fiscal year 2025 earnings conference call. (Operator Instructions)
I'd now like to turn the call over to Sarika Dhadwal, Senior Director of Investor Relations. You may begin.
Good morning. Thank you for joining Donaldson's first-quarter fiscal 2025 earnings conference call. With me today are Tod Carpenter, Chairman, President and CEO; and Brad Pogalz, Chief Financial Officer. Also on the call is Scott Robinson, former CFO and current Strategic Adviser. This morning, Tod and Brad will provide a summary of our first-quarter performance and reaffirm our outlook for fiscal 2025.
During today's call, we will discuss non-GAAP or adjusted results. For first quarter 2025, non-GAAP results exclude pretax restructuring and other charges of $3.3 million, primarily related to cost reduction initiatives in the life sciences segment. A reconciliation of GAAP to non-GAAP metrics is provided within the schedules attached to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
